Trinity Legacy Partners’s Abbott ABT Stock Holding History

Trinity Legacy Partners’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,300	Closed	-$2K	–	105
2021 Q2	$2K	Sell	1,300 -200	-13%	-$23.3K	﹤0.01%	107
2021 Q1	$3K	Buy	+1,500	New	+$178K	﹤0.01%	95

Other funds holding ABT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Trinity Legacy Partners's ABT Position: Q2 2026 in Review

Trinity Legacy Partners sold out of Abbott (ABT) in Q2 2026, closing a stake of 2,685 shares — an estimated $271K sold.

Trinity Legacy Partners first reported a position in ABT in Q1 2021 and held it in 11 quarters. The position peaked at $2.37M in Q4 2025. 2,968 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

Trinity Legacy Partners reported no remaining Abbott position as of Q2 2026 after selling out during the quarter.
Trinity Legacy Partners sold 2,685 Abbott shares in Q2 2026, an estimated $271K.
Trinity Legacy Partners first reported a position in Abbott in Q1 2021 and held it in 11 quarters.
Trinity Legacy Partners's Abbott position peaked at $2.37M in Q4 2025.
2,968 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Trinity Legacy Partners's 13F filing for Q2 2026, filed 24 Jul 2026.